$91.01
-0.13-0.14%
al cierre: -
$91.01
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Orientación y previsiones
ANI Pharmaceuticals emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/08/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.98 | $7.35 | $6.52 | $818.00M | $843.00M | $788.08M | |
06/04/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.27 | $6.62 | $6.52 | $768.00M | $793.00M | $788.08M | |
05/09/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.27 | $6.62 | $6.52 | $768.00M | $793.00M | $788.08M | |
02/28/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.12 | $6.49 | $6.52 | $756.00M | $776.00M | $788.08M | |
01/13/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | — | — | — | $739.00M | $759.00M | $788.08M | |
11/08/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.90 | $5.05 | $5.01 | $594.00M | $602.00M | $599.18M | |
08/06/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.38 | $4.82 | $5.01 | $540.00M | $560.00M | $599.18M | |
05/14/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | — | — | — | $520.00M | $542.00M | $599.18M | |
05/10/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $5.01 | $520.00M | $542.00M | $599.18M | |
04/17/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $5.01 | $520.00M | $542.00M | $599.18M | |
03/12/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.46 | $520.00M | $542.00M | $535.28M | |
02/29/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.33 | $520.00M | $542.00M | $501.09M | |
11/08/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $4.29 | $4.57 | $4.08 | $468.00M | $478.00M | $452.94M | |
09/12/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.97 | $425.00M | $445.00M | $442.97M | |
08/30/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.97 | $425.00M | $445.00M | $442.97M | |
08/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.31 | $425.00M | $445.00M | $406.41M | |
06/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | — | — | — | $385.00M | $410.00M | $403.52M | |
05/08/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $2.99 | $3.45 | $2.43 | $385.00M | $410.00M | $361.82M | |
03/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $2.09 | $2.59 | $2.62 | $360.00M | $385.00M | $352.49M | |
11/09/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.37 | $295.00M | $315.00M | $302.88M | |
08/08/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.43 | $295.00M | $315.00M | $304.50M | |
05/10/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.15 | $295.00M | $315.00M | $292.77M | |
03/15/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | — | — | — | $260.00M | $275.00M | $301.57M |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de ANI Pharmaceuticals (ANIP)?
La orientación más reciente para ANI Pharmaceuticals (ANIP) se informó el agosto 8, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $6.98 a $7.35, en comparación con el EPS estimado de $6.52. Además, ANI Pharmaceuticals pronosticó ingresos entre $0.82B y $0.84B para el trimestre.
Explora orientación y previsión sobre todos los valores.